LY2157299 is a TGF-beta type I receptor kinase inhibitor. LY2157299 has been used to inhance chemotherapy action against triple negative breast cancer (TNBC). Molecular Formula: C22H19N5O Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 369.42 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
369.42
Formulierung:
Supplied as a white to off-white solid.
CAS Nummer:
[700874-72-2]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten